Each year, the UBC Faculty of Medicine recognizes faculty and staff members for excellence in teaching, research, administration, innovation and public service. This year, Dr Zoubeidi was awarded a UBC Faculty of Medicine Distinguished Achievement Award for Excellence in Basic Science Research, in recognition of meritorious performance.
Dr Martin Gleave is the recipient of the fifth annual Dr Chew Wei Memorial Prize in Cancer Research for his work to improve outcomes from prostate cancer, which has spanned surgery, molecular manipulation in the search for new treatments, and managing the challenge of taking lab discoveries to market. The UBC Faculty of Medicine bestows this award annually to a Canadian physician or scientist who makes outstanding co
Drs. Zoubeidi, Black and So are PIs on three CIHR Project Grants that were funded in the March 2018 competition. The funded projects are:
Dr. Amina Zoubeidi: Hormone therapy induces reprogramming to drive aggressive prostate cancer ($669,376 over 5 years)
- Ranked 1st of 39 projects in the Cancer Biology & Therapeutics 2 Committee's review panel
Drs. Peter Black & Purang Abolmaesumi: Multi-centre Temporal Ultrasound Image Analysis for Prostate Cancer Diagnosis ($1,158,976 over 5 years)
Vancouver Coastal Health Research Institute (VCHRI) supports tomorrow’s research leaders with the Top Graduating Doctoral Student Awards and the Rising Star Awards. These awards recognize outstanding contributions by VCHRI research trainees to research excellence, service as role models, and other contributions to the VCH research community.
The Vancouver Sun is running a five-part series on prostate cancer, written by Larry Pynn. Links will be added as stories are published.
Part 1: Shock and choices after the diagnosis
1 in 7 Canadian men get prostate cancer, and I am among them
Dr Peter Black has been awarded an MSFHR Health Professional-Investigator award in partnership with Vancouver Coastal Health Research Institute and VGH & UBC Hospital Foundation. The project, "Unraveling disparate roles of Notch-1 and Notch-2 signaling in bladder cancer" will further his ongoing work on the Notch signaling pathway in bladder cancer. Loss of the cell surface receptor Notch-1 drives growth of some bladder cancers, while increased Notch-2 activity drives other bladder cancers.
The Prostate Cancer Foundation (USA) published a news release on the development...
April 19, 2018 - The National Post article "Good economics and good health: How Canada’s pharmaceutical companies make an impact" describes how pharmaceutical companies partner with academic institutions to expedite therapeutic discoveries. In its interview with Brad Wheeler of the University of British Columbia's University-Industry Liaison Office, the Vancouver Prostat